LAUREN CIESLAK: Open Payments
NPI 1770198137 · DEARBORN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$591 in 29 payments from 10 companies in 2025. Trend: 2023 $153 · 2024 $423 · 2025 $591
Food & beverage: $591
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 9 | $195 |
| GlaxoSmithKline, LLC. | 6 | $103 |
| Insmed, Inc. | 4 | $77 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $58 |
| Verona Pharma, Inc. | 2 | $46 |
| Viatris Specialty LLC | 1 | $30 |
| Actelion Pharmaceuticals US, Inc. | 1 | $26 |
| Grifols USA, LLC | 1 | $23 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: DUPIXENT, NUCALA, Arikayce, Ohtuvayre, OFEV, YUPELRI, OPSUMIT, Prolastin-C Liquid.
Industry payments across MI — which companies pay providers there.
